JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 19, 2006; DOI: 10.1124/jpet.106.102251


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.102251v1
318/1/389    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furst, R.
Right arrow Articles by Vollmar, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furst, R.
Right arrow Articles by Vollmar, A. M.


Received for publication February 3, 2006.
Revised April 18, 2006.
Accepted for publication April 18, 2006.

NF-{kappa}B-independent anti-inflammatory action of salicylate in human endothelial cells: induction of heme oxygenase-1 by the JNK/AP-1 pathway

Robert Furst 1*, Signe B. Blumenthal 1, Alexandra K. Kiemer 2, Stefan Zahler 1, Angelika M. Vollmar 1

1 Department of Pharmacy, Pharmaceutical Biology, University of Munich, Germany 2 Institute of Pharmaceutical Biology, Saarland University, Saarbrucken, Germany

* Address correspondence to: E-mail: robert.fuerst{at}cup.uni-muenchen.de

Abstract

In contrast to aspirin, salicylate, its active metabolite, possesses profound anti-inflammatory properties without blocking cyclooxygenase. Inhibition of the transcription factor NF-{kappa}B has been discussed to play a role in the anti-inflammatory profile of salicylate. However, in addition, NF-{kappa}B-independent effects of salicylate have been assumed, but have as yet been poorly investigated. Therefore, aim of the present study was to investigate NF-{kappa}B-independent anti-inflammatory mechanisms of salicylate in human umbilical vein endothelial cells (HUVEC) using IL-4 as NF-{kappa}B-independent pro-inflammatory stimulus and P-selectin as inflammatory read-out parameter. Using quantitative real-time RT-PCR, we found that salicylate decreases IL-4-induced P-selectin expression. As judged by Western blot analysis, salicylate increased endothelial heme oxygenase-1 (HO-1) protein levels. Employing both the HO-1 inhibitor SnPP and HO-1 antisense oligonucleotides, we causally linked the induction of HO-1 to the decrease of P-selectin. Moreover, we were interested in the signaling mechanisms leading to the upregulation of HO-1 by salicylate. JNK was found to be activated by salicylate and we could causally link this activation to the induction of HO-1 by using the JNK inhibitor SP600125. By applying AP-1 decoys, it was shown that the transcription factor AP-1 is crucially involved in the upregulation of HO-1 downstream of JNK. In summary, our study introduces HO-1 as novel NF-{kappa}B-independent anti-inflammatory target of salicylate in human endothelial cells. Moreover, we elucidated the JNK/AP-1 pathway as crucial for the induction of HO-1 by salicylate.


Key words: P-selectin, endothelium, heme oxygenase, inflammation, interleukin-4, salicylate


This article has been cited by other articles:


Home page
EndocrinologyHome page
R. Furst, S. Zahler, and A. M. Vollmar
Dexamethasone-Induced Expression of Endothelial Mitogen-Activated Protein Kinase Phosphatase-1 Involves Activation of the Transcription Factors Activator Protein-1 and 3',5'-Cyclic Adenosine 5'-Monophosphate Response Element-Binding Protein and the Generation of Reactive Oxygen Species
Endocrinology, July 1, 2008; 149(7): 3635 - 3642.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.